A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial.

Details

Language :

English

ISSN :

1048891X

Volume :

34

Issue :

4

Database :

Supplemental Index

Journal :

International Journal of Gynecological Cancer

Publication Type :

Academic Journal

Accession number :

177174625

Full Text :

https://doi.org/10.1136/ijgc-2023-005189